Study Stopped
Potential participants to date all had etiological factors for their sexual dysfunction additional to the antidepressant. Thus they all had exclusion criterior
Mindfulness for Antidepressant-induced Sexual Symptoms
MASS
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
Antidepressant-induced sexual dysfunction (AISD) affects the majority of women taking antidepressants and reduces medication compliance: however there is a paucity of evidence-based strategies for the management of this condition. Mindfulness-based cognitive therapy (MBCT) has been shown to be effective in the treatment of non-antidepressant-induced sexual dysfunction and may be beneficial in the treatment of AISD. The investigators propose a randomized, controlled, proof-of-principle trial to establish preliminary evidence of efficacy of MBCT in AISD and to inform the design of a larger trial to evaluate its effectiveness
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jul 2016
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 6, 2016
CompletedFirst Posted
Study publicly available on registry
May 11, 2016
CompletedStudy Start
First participant enrolled
July 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2018
CompletedOctober 26, 2017
October 1, 2017
1.4 years
May 6, 2016
October 24, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
group difference on change in CSFQ-14 score after intervention
The researchers will calculate an 80% confidence interval for the between group difference on change in CSFQ-14 score pre to post intervention using a linear mixed model that includes treatment, time and time-by-treatment as fixed effects and patient as a random effect. If the confidence interval excludes 0 the researchers will consider this preliminary evidence of efficacy.
18 months
Secondary Outcomes (1)
Estimation of the minimal clinically important improvement
18 months
Study Arms (2)
mindfulness-based cognitive therapy
ACTIVE COMPARATORThe practice of mindfulness will be followed plus the basics of cognitive therapy given in small group format.
waitlist
NO INTERVENTIONWomen diagnosed with AISD randomised to wait list will receive no active treatment during the trial period.
Interventions
Six two-hour small group sessions (6-9 participants) will be administered over 8 weeks focusing on MBCT. The intervention follows a written protocol to ensure fidelity of delivery. Participants will receive detailed manuals summarizing session content and home assignments (HAs), including mindfulness practices, audio versions of which will be available on an internet link.
Eligibility Criteria
You may qualify if:
- participants need to be:
- referred to the Sexual Medicine Clinic
- women 19 years of age or older
- fulfilling the DSM-5 criteria for clinical diagnosis of AISD for at least 4 weeks, confirmed by Changes in Sexual Functioning Questionnaire (CSFQ-14) total score of 41 or below
- on a therapeutic dose of antidepressant for at least 8 weeks and on a stable dose for at least 4 weeks
- in clinical remission from depression and/or anxiety, confirmed by a Patient Health Questionnaire (PHQ-9) score of less than 5, and a Generalized Anxiety Disorder-7 (GAD-7) score of less than 10, respectively
- willing to commit to adhere to their antidepressant regimen for the duration of the trial (20 weeks) unless medically contraindicated
- willing to commit to attend to all group sessions, homework assignments, and questionnaires
- the referring physician commits to continued provision of mental health care throughout the study
You may not qualify if:
- history of SD prior to being started on current antidepressant except SD secondary to clinical depression, or AISD
- chronic pain with intercourse not relieved with lubricants
- primary psychiatric disorder other than a depressive or anxiety disorder
- alcohol/substance abuse
- general medical illnesses known to impair sexual function including but not limited to cancer, neurological, endocrine, renal, and cardiovascular conditions
- non-antidepressant medication induced SD (70)
- receiving other concurrent pharmacological or psychological interventions for SD
- positive screen for borderline personality disorder, due to the high prevalence of sexual difficulties (70, 71), and the potential destabilizing effect of mindfulness meditation in those affected (72)
- previous formal practice of mindfulness meditation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
May 6, 2016
First Posted
May 11, 2016
Study Start
July 1, 2016
Primary Completion
December 1, 2017
Study Completion
July 1, 2018
Last Updated
October 26, 2017
Record last verified: 2017-10
Data Sharing
- IPD Sharing
- Will not share